Related Experiment Video
Updated: May 5, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.5K
Options in obesity management
1Department of Medicine, Monash University, Monash Medical Centre, Melbourne, Victoria, Australia.
Asia Pacific Journal of Clinical Nutrition
|December 11, 2013
Summary
Obesity management recognizes individual differences in causes and lifestyle. Prioritizing physical activity and diverse health endpoints is key for effective, long-term obesity control.
Area of Science:
- Endocrinology and Metabolism
- Public Health
- Behavioral Medicine
Background:
- Obesity is a complex condition with varied causes, including genetics, lifestyle, and psychological factors.
- Effective obesity management requires acknowledging its heterogeneity and tailoring interventions accordingly.
- Traditional approaches often focus solely on weight loss, neglecting other crucial health indicators.
Purpose of the Study:
- To highlight the heterogeneous nature of obesity and its implications for management.
- To emphasize the importance of physical activity and diverse health endpoints in obesity treatment.
- To discuss the range of management options and their associated risks.
Main Methods:
- Review of existing literature on obesity management strategies.
- Analysis of factors contributing to obesity heterogeneity.
- Discussion of various therapeutic approaches, including behavioral, pharmacological, and surgical interventions.
Main Results:
- Negative energy balance can be achieved through varied energy intake and physical activity levels.
- Increased physical activity is preferred for long-term management over solely reduced food intake.
- Management endpoints should include body fat distribution (e.g., abdominal girth), self-esteem, fitness, and disease risk, not just weight.
Conclusions:
- Personalized obesity management acknowledging individual differences is crucial.
- A multi-faceted approach incorporating physical activity, behavioral changes, and diverse health goals is most effective.
- Prevention strategies should focus on early risk detection, health education, and lifestyle modifications.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
440
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients
368
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
324
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K

